Výsledky vyhledávání - "Yannis, Metaxas"

Akademický článek

Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment

Autor: Sabine Schmid, MD, Lisa Holer, MSc, Katrin Gysel, MSc, Kira-Lee Koster, MD, Sacha I. Rothschild, MD, Laura A. Boos, MD, Lorenz Frehner, MD, Sabine Cardoso Almeida, MD, Christian Britschgi, MD, PhD, Yannis Metaxas, MD, Michael Mark, MD, Patrizia Froesch, MD, Wolf-Dieter Janthur, MD, Anna Allemann, MD, Christine Waibel, MD, Catherine Von der Mühll-Schill, MD, Martin Früh, MD, Laetitia A. Mauti, MD, PhD

Publikováno v: JTO Clinical and Research Reports, Vol 5, Iss 12, Pp 100735- (2024)

Objectives: On the basis of the positive results of CheckMate-743, first-line (1L) treatment of malignant pleural mesothelioma (MPM) with the combination of ipilimumab and nivolumab (ipi-nivo) has become a standard-of-care. Furthermore, patients who

Externí odkaz: https://doaj.org/article/eaf1ac72cdcf42a0a92d67407c36e4ea

Zobrazit plný text záznamu

Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA)

Publikováno v: Cancers; Volume 14; Issue 9; Pages: 2191

Purpose: These are the final results of a national registry on cancer patients with COVID-19 in Switzerland. Methods: We collected data on symptomatic COVID-19-infected cancer patients from 23 Swiss sites over a one-year period starting on 1 March 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faf06d2061552218e2cc02fc1ce77c7c

Zobrazit plný text záznamu

Plný text ve formátu HTML

Old drug, new clinical use, no man's land for the indication: an awareness call from European experts

Autor: Yannis Metaxas, George Pentheroudakis, Panagiotis Ntellas, Jean-Yves Douillard, Alexandra Papadaki, Ioanna Gazouli, Stefania Gkoura, Davide Mauri, Leonidas Mavroeidis, Stefan Rauh

Publikováno v: ESMO Open

Licence holders of a new medical agent who apply for marketing authorisation in Europe have two choices: They may either apply to a national health authority (which limits authorisation to the authority’s country) or choose the centralised procedur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dbc7be82dc7288ed4ba0b0ce951eaf9
https://pubmed.ncbi.nlm.nih.gov/33551069

Zobrazit plný text záznamu

CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia

Autor: C Porzelius, Jürgen Finke, Yannis Metaxas, M Spyroupoulou-Vlachou, Alexandros Spyridonidis, Hartmut Bertz

Publikováno v: Bone Marrow Transplantation. 47:411-415

The benefit of survival at the expense of new GVHD after DLI for acute leukemia following human allogeneic hematopoietic cell transplantation (allo-HCT) remains a matter of controversy. The detection of biological markers predicting this outcome woul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d8dcb4136d35f307a49e585f7c0dbd
https://doi.org/10.1038/bmt.2011.101

Zobrazit plný text záznamu

Horizontal DNA and mRNA transfer between donor and recipient cells after allogeneic hematopoietic cell transplantation?

Autor: Eleni D. Lagadinou, Jürgen Finke, Maria Themeli, Yannis Metaxas, Miguel Waterhouse, Alexandros Spyridonidis

Publikováno v: Waterhouse, M, Themeli, M, Metaxas, Y, Lagadinou, E D, Finke, J & Spyridonidis, A 2009, ' Horizontal DNA and mRNA transfer between donor and recipient cells after allogeneic hematopoietic cell transplantation? ', Frontiers in Bioscience, vol. 14, no. 7, pp. 2704-2713 . https://doi.org/10.2741/3407
Frontiers in Bioscience, 14(7), 2704-2713. Frontiers in Bioscience

Allogeneic hematopoietic cell transplantation in humans results in true biological chimeras. There is now accumulating evidence that besides Graft versus Host Disease (GvHD), there are also other consequences in the co-existence of two genetically di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1002916142cb158894776725e41c6c44
http://www.scopus.com/inward/record.url?scp=63849318104&partnerID=8YFLogxK

Zobrazit plný text záznamu

Stem Cell Plasticity: The Debate Begins to Clarify

Autor: Jürgen Finke, Alexandros Spyridonidis, Marie Follo, Robert Zeiser, Yannis Metaxas

Publikováno v: Stem Cell Reviews. 1:037-044

The stem cell story begins with the recognition of the regenerative powers of the head of the Lernean Hydra and the human liver (Prometheus) by the ancient Greeks. In modern times, the adult human stem cell has been epitomized by the hematopoietic st

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37ba13315f086f0f9a47402eaf640dea
https://doi.org/10.1385/scr:1:1:037

Zobrazit plný text záznamu

Update on clinical research and state of the art management of patients with advanced sarcomas and GIST

Autor: George Pentheroudakis, Georgios Oikonomopoulos, Yannis Metaxas

Publikováno v: ESMO Open

Sarcomas constitute a rare group of malignancies. According to histology, different treatment options are effective. For gastrointestinal stromal tumours (GISTs), targeted treatment with imatinib controls about 20% of advanced or metastatic disease,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d080e4b58dbf13791fdc4f1d2317b2
https://doi.org/10.1136/esmoopen-2016-000065

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání